Safety and efficacy concerns in menopause supplements

Research and consumer advocacy have highlighted significant safety, efficacy, and value concerns regarding menopause supplements in the United Kingdom.

A study by University College London (UCL) examined 201 products, identifying a “menopause gold rush” characterized by inconsistent dosages and a lack of essential nutrients. Researchers noted that many products failed to meet health recommendations, such as containing no vitamin D, and warned of potential health risks including toxic liver damage. The study also pointed to the role of social media influencers in spreading misinformation.

Following these concerns, the consumer watchdog Which? reviewed 26 supplements and found that none provided the correct balance or dosage of nutrients specifically required for menopause. The watchdog identified a practice termed “fairy-dusting,” where key nutrients are included in doses too low to be beneficial. Which? suggested that high-priced blends are often no more effective than budget-friendly multivitamins, recommending targeted supplementation as a more cost-effective alternative.